Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3218396
Max Phase: Preclinical
Molecular Formula: C39H60N16O16
Molecular Weight: 1009.00
Molecule Type: Small molecule
Associated Items:
ID: ALA3218396
Max Phase: Preclinical
Molecular Formula: C39H60N16O16
Molecular Weight: 1009.00
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@H]1[C@H]([C@H](OC(=O)NCCCn2cc(CCCc3cn(CCCNC(=O)O[C@@H]([C@@H]4OC(C(=O)O)=C[C@H](NC(=N)N)[C@H]4NC(C)=O)[C@H](O)CO)nn3)nn2)[C@H](O)CO)OC(C(=O)O)=C[C@@H]1NC(=N)N
Standard InChI: InChI=1S/C39H60N16O16/c1-18(58)46-28-22(48-36(40)41)12-26(34(62)63)68-32(28)30(24(60)16-56)70-38(66)44-8-4-10-54-14-20(50-52-54)6-3-7-21-15-55(53-51-21)11-5-9-45-39(67)71-31(25(61)17-57)33-29(47-19(2)59)23(49-37(42)43)13-27(69-33)35(64)65/h12-15,22-25,28-33,56-57,60-61H,3-11,16-17H2,1-2H3,(H,44,66)(H,45,67)(H,46,58)(H,47,59)(H,62,63)(H,64,65)(H4,40,41,48)(H4,42,43,49)/t22-,23-,24+,25+,28+,29+,30+,31+,32+,33+/m0/s1
Standard InChI Key: OPDBZXBRYPKJQP-BVXSRWBHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1009.00 | Molecular Weight (Monoisotopic): 1008.4373 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Fraser BH, Hamilton S, Krause-Heuer AM, Wright PJ, Greguric I, Tucker SP, Draffan AG, Fokin VV, Sharpless KB. (2013) Synthesis of 1,4-triazole linked zanamivir dimers as highly potent inhibitors of influenza A and B, 4 (2): [10.1039/C2MD20300F] |
Source(1):